10Y annualized return is
positive but below market average
at 5.4% per year
HOLX has met or exceeded earnings expectations in
most
recent quarters (9/10)
Moderate Price to Earnings Ratio
Strong Gross and Net Profit Margins
High Price to Sales Ratio
Operating Profit Margin Could Improve
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Hologic demonstrates a solid business model with strong financial performance and market-leading products, yet faces challenges with declining segments and revised growth expectations. Future prospects hinge on successful product launches and acquisitions, although economic headwinds pose risks.
Analysis Date: February 5, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Hologic, Inc. is a healthcare company that focuses on women's health. They create and sell medical tools and tests that help doctors detect and treat health issues early, like infections and cancers. Some of their main products include tests for diseases like HIV and COVID-19, as well as imaging systems for breast exams. They also offer surgical products to help with issues like heavy bleeding or removing growths in the uterus. Overall, Hologic is dedicated to improving women's health through innovative medical solutions.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect HOLX's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact HOLX's performance.
Access Full Risk AnalysisLatest News
In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within th...
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental A...
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights